Literature DB >> 17376441

Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst.

Stéphane Jaisson1, Céline Delevallée-Forte, Fatouma Touré, Philippe Rieu, Roselyne Garnotel, Philippe Gillery.   

Abstract

Carbamylation is a post-translational modification of proteins characterized by the binding of cyanate to amino groups, increased in renal failure. Pathophysiological consequences of carbamylation and adverse effects of carbamylated proteins on cell functions are poorly understood. We studied the influence of carbamylated albumin on polymorphonuclear neutrophil (PMN) O(2)(-) production. Carbamylated albumin significantly decreased O(2)(-) production in PMNs stimulated by type I collagen, but not by phorbol 12-myristate 13-acetate or tumor necrosis factor-alpha. This effect was related to inhibition of p(125)FAK phosphorylation. Such an alteration of neutrophil oxidative functions might explain characteristic complications of renal failure, such as increased occurrence of inflammation or infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376441     DOI: 10.1016/j.febslet.2007.03.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Cyanate is a novel inducer of endothelial icam-1 expression.

Authors:  Dalia El-Gamal; Michael Holzer; Martin Gauster; Rudolf Schicho; Veronika Binder; Viktoria Konya; Christian Wadsack; Rufina Schuligoi; Akos Heinemann; Gunther Marsche
Journal:  Antioxid Redox Signal       Date:  2011-10-14       Impact factor: 8.401

Review 2.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

Review 3.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

4.  Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.

Authors:  Piotr Mydel; Zeneng Wang; Mikael Brisslert; Annelie Hellvard; Leif E Dahlberg; Stanley L Hazen; Maria Bokarewa
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

5.  Physicochemical characterization of carbamylated human serum albumin: an in vitro study.

Authors:  Asim Badar; Zarina Arif; Shireen Naaz Islam; Khursheed Alam
Journal:  RSC Adv       Date:  2019-11-11       Impact factor: 4.036

Review 6.  Avenues for post-translational protein modification prevention and therapy.

Authors:  Mengyao Tang; Sahir Kalim
Journal:  Mol Aspects Med       Date:  2022-02-25

7.  Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.

Authors:  Sahir Kalim; Caitlin A Trottier; Julia B Wenger; Josh Wibecan; Rayhnuma Ahmed; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani; Anders H Berg
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

8.  Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.

Authors:  Alastair J O'Brien; James N Fullerton; Karen A Massey; Grace Auld; Gavin Sewell; Sarah James; Justine Newson; Effie Karra; Alison Winstanley; William Alazawi; Rita Garcia-Martinez; Joan Cordoba; Anna Nicolaou; Derek W Gilroy
Journal:  Nat Med       Date:  2014-04-13       Impact factor: 53.440

9.  Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.

Authors:  Anders H Berg; Christiane Drechsler; Julia Wenger; Roberto Buccafusca; Tammy Hod; Sahir Kalim; Wenda Ramma; Samir M Parikh; Hanno Steen; David J Friedman; John Danziger; Christoph Wanner; Ravi Thadhani; S Ananth Karumanchi
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

Review 10.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.